These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
734 related items for PubMed ID: 8672777
1. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences]. Venz S, Hosten N, Ilg J, Mäurer J, Podrabsky P, Fedel M, Ebert T, Nagel R. Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777 [Abstract] [Full Text] [Related]
2. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. Venz S, Ilg J, Ebert T, Hierholzer J, Friedrichs R, Hosten N, Felix R. Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358 [Abstract] [Full Text] [Related]
3. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior]. Doringer E, Joos H, Forstner R, Schmoller H. Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149 [Abstract] [Full Text] [Related]
4. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. Scattoni V, Da Pozzo LF, Colombo R, Nava L, Rigatti P, De Cobelli F, Vanzulli A, Del Maschio A. J Urol; 1996 May; 155(5):1594-9. PubMed ID: 8627831 [Abstract] [Full Text] [Related]
5. [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?]. Sparenberg A, Hamm B, Hammerer P, Samberger V, Wolf KJ. Rofo; 1991 Aug; 155(2):117-22. PubMed ID: 1878537 [Abstract] [Full Text] [Related]
6. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance]. Torricelli P, Montanari N, De Santis M, Pollastri C. Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898 [Abstract] [Full Text] [Related]
7. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media]. De Cobelli F, Vanzulli A, Colombo E, Bonato C, Sironi S, Del Maschio A. Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756 [Abstract] [Full Text] [Related]
9. [Magnetic resonance imaging of bladder tumors: superiority of serial "Fast SE" assisted by Gd-DTPA in tumor staging]. Tanimoto A, Yuasa Y, Endo M, Ohkawa S, Shiraga N, Fujisawa H, Ido K, Ogawa K, Momoshima S, Shiga H. Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Dec 25; 49(12):1552-66. PubMed ID: 2633133 [Abstract] [Full Text] [Related]
11. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases]. Allgayer B, Lukas P, Loos W, Kersting-Sommerhoff B. Rofo; 1993 May 25; 158(5):423-7. PubMed ID: 8490150 [Abstract] [Full Text] [Related]
12. [Magnetic resonance tomography of the oropharynx and oral cavity with Gd-DTPA. An optimized study technic and its diagnostic value]. Vogl T, Dresel S, Steger W, Grevers G, Lissner J. Rofo; 1991 Apr 25; 154(4):375-82. PubMed ID: 1850152 [Abstract] [Full Text] [Related]
13. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver]. Zhang HM, Ouyang H, Zhou CW. Zhonghua Zhong Liu Za Zhi; 2006 Feb 25; 28(2):111-5. PubMed ID: 16750014 [Abstract] [Full Text] [Related]
14. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil]. Heuck A, Scheidler J, Kimmig R, Müller-Lisse U, Steinborn M, Helmberger T, Reiser M. Rofo; 1997 Mar 25; 166(3):210-4. PubMed ID: 9156591 [Abstract] [Full Text] [Related]
15. [Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA]. Nishimura K, Hida S, Nishio Y, Yoshida O, Nakano Y. Hinyokika Kiyo; 1988 Dec 25; 34(12):2097-100. PubMed ID: 3239521 [Abstract] [Full Text] [Related]
16. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences. Stimac GK, Porter BA, Olson DO, Gerlach R, Genton M. AJR Am J Roentgenol; 1988 Dec 25; 151(6):1185-92. PubMed ID: 3055895 [Abstract] [Full Text] [Related]
18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media]. Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D. Radiol Med; 2000 Sep 25; 100(3):160-7. PubMed ID: 11148882 [Abstract] [Full Text] [Related]
19. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV. Invest Radiol; 2010 May 25; 45(5):233-44. PubMed ID: 20351653 [Abstract] [Full Text] [Related]
20. [The MRT of the orbit: the value of T1-weighted frequency-selective fat saturation at 1.0 and 1.5 tesla]. Link TM, Reimer P, Rummeny EJ, Schuierer G, Grenzebach U, Peters PE. Rofo; 1995 Nov 25; 163(5):406-10. PubMed ID: 8527754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]